NOVA Score (Nosocomial vs Community IE) Calculator
Clinical criteria
For patients with enterococcal bloodstream infection; select each finding based on the clinical assessment.
Interpret in the context of the organism, blood-culture pattern, clinical suspicion, and local prevalence. A low score does not independently exclude infective endocarditis.
The original proposed threshold was ≥4 points to identify patients for further evaluation, including consideration of transesophageal echocardiography (TEE). Do not use this score alone to decide against echocardiography when clinical suspicion remains.
About the NOVA score
The NOVA score is a clinical risk-stratification tool proposed to help identify patients with enterococcal bacteremia who may have infective endocarditis and require echocardiographic assessment. It is not a diagnostic criterion for IE and is not a score for distinguishing nosocomial from community-acquired IE.
Criteria and weights
| Criterion | Definition | Points |
|---|---|---|
| N — Number | 3/3 positive blood cultures, or majority positive if more than 3 are obtained | 5 |
| O — Origin | Unknown origin of bacteremia | 4 |
| V — Valve | Predisposing heart valve disease | 2 |
| A — Auscultation | Heart murmur on auscultation | 1 |
Score interpretation
| Total | Interpretation |
|---|---|
| 0–3 | Below the original proposed threshold; lower likelihood, but IE is not excluded. |
| ≥4 | At or above the proposed threshold; further evaluation for IE, including consideration of TEE, is warranted in clinical context. |
The external validation by Dahl et al. used an adapted blood-culture criterion (2/2 positive cultures, or more than half positive when more than two cultures were obtained). This calculator uses the original published criterion and should not be interpreted as the adapted version.
References
Clinical notes
Document key findings and keep a structured record for your own reference.
My notes
Review, edit, or remove notes saved in this browser.
Report an issue
Your feedback helps us improve the reliability and usability of this clinical tool.